Researchers have found that new myelin-making cells are constantly being made in the brain and spinal cord, even in the ...

Molecular imaging is redefining in vivo characterization of multiple sclerosis, a demyelinating disease with complex and heterogeneous clinical profiles. Recent advances in PET tracers enable more ...

Autoimmune diseases such as multiple sclerosis arise when the immune system turns against the body itself. Yet for most of them, it remains unclear why this process begins. Researchers have now ...

A newly identified mechanism lends credence to the idea that MS may be treatable by targeting EBV-infected B-cells, a study found.

Multiple sclerosis may quietly damage the brain for years before symptoms appear, and scientists can now see it coming.

In experiments with mice, Johns Hopkins Medicine scientists report new evidence that precursors of myelin-producing cells—one of the few brain cell types that continue to be produced in the adult ...

Clinicians discuss the rapidly evolving therapies, technology, and surgical approaches for early-stage NSCLC and take a fresh look at the future of care. Teamwork: A Multidisciplinary Approach to ...

The central role of Epstein-Barr virus in causing multiple sclerosis is examined to understand how it triggers the disease and presents new opportunities for treatment “Evidence is mounting that you ...